Poster Session 27: Aspirin-Exacerbated Respiratory Disease

Tuesday, 6 December 2011: 12:15 - 14:15
Poster Hall (Cancún Center)
3087
Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation | Karl-Christian Bergmann (Germany)
3088
Relationship Between Aeroallergen Sensitization and Asthma Severity in Patients with Aspirin-Exacerbated Respiratory Disease | Chihiro Mitsui (Japan)
3089
Persistence of Nasal and Bronchial Symptoms in Patients with Samter's Syndrome with Treatment Medical and Surgical in a 2 Year Period | Hugo Alberto Azuara Trujillo (Mexico)
3090
Clinics and Laboratory Characteristics of Asthmatic Patients with Aspirin Exacerbated Respiratory Disease (AERD) Pedro Giavina-Bianchi (Brazil)
3091
Association Analysis of Member RAS Oncogene Family Gene Polymorphisms with Aspirin Intolerance in Asthmatic Patients Tae-Hoon Kim (South Korea)
3092
Nasal Nitric Oxide Levels After Lysine Aspirin Nasal Challenge In Subjects with Aspirin Induced Asthma | Damian Tworek (Poland)
3093
IL1B but Not IL8 Polymorphisms Are Increased in Aspirin Exacerbated Respiratory Disease Patients Versus Aspirin Tolerant Asthmatics | Fernando Gandhi Pavon Romero (Mexico)
3094
Fatty Acid Binding Protein 1 Is Related with Development of Aspirin-Exacerbated Respiratory Disease | Tae-Hoon Kim (South Korea)
See more of: Poster Session
See more of: Abstract Presentations
<< Previous Session | Next Session >>